Clinical Trials
2 trialsNCT07622836 2026-06-03
A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting
NCT07491822 2026-03-24
A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase NA Not yet recruiting